Shares of Genflow Biosciences plc (LON:GENF – Get Free Report) traded down 5.8% during mid-day trading on Tuesday . The stock traded as low as GBX 1.84 and last traded at GBX 1.84. 825,230 shares traded hands during mid-day trading, a decline of 53% from the average session volume of 1,751,176 shares. The stock had previously closed at GBX 1.95.
Genflow Biosciences Price Performance
The stock has a fifty day moving average of GBX 1.86 and a 200 day moving average of GBX 1.47. The firm has a market capitalization of £9.43 million, a P/E ratio of -3.80 and a beta of 2.37.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The biggest scam in the history of gold markets is unwinding
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
